The agency has defined the recall of the Cardiosave Hybrid/Rescue intra-aortic balloon pumps as class 1, the most serious type of recall, meaning use of the device could cause serious injury or death.
Getinge has received 71 complaints related to the recall issue and one reported death.
The intra-aortic balloon pumps are used to treat adults with acute coronary syndrome or heart failure complications.
The recall is the second related to the intra-aortic balloon pumps since Nov. 1, when the company issued a recall of 137 battery packs.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
